Svetlana Paskas, Philipp Stockmann, Sanja Mijatović, Lydia Kuhnert, Walther Honscha, Evamarie Hey-Hawkins, & Danijela Maksimović-Ivanić. (2023). Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. MDPI AG.
Chicago Style (17th ed.) CitationSvetlana Paskas, Philipp Stockmann, Sanja Mijatović, Lydia Kuhnert, Walther Honscha, Evamarie Hey-Hawkins, and Danijela Maksimović-Ivanić. Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. MDPI AG, 2023.
MLA (9th ed.) CitationSvetlana Paskas, et al. Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.